Transcranial Pulse Stimulation (TPS) in Post-COVID-19

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 8, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Post-COVID-19 SyndromeFatigue
Interventions
DEVICE

Transcranial pulse stimulation Verum

Participants are slated to undergo a total of five TPS sessions over a 10-day interval. Each stimulation session will endure approximately 30 minutes and will be administered once daily.

DEVICE

Transcranial pulse stimulation Sham

Placebo treatment will be performed using the same medical device, handpiece and treatment paradigm as in the verum treatment with one difference: the standoff device at the end of the handpiece. This device is designed to replicate the appearance, feel, and sound of the verum system, while omitting the transmission of any pulses.

Trial Locations (2)

1090

RECRUITING

Medical University of Vienna, Vienna

00128

NOT_YET_RECRUITING

Università Campus Bio-Medico di Roma, Rome

All Listed Sponsors
collaborator

Campus Bio-Medico University

OTHER

lead

Medical University of Vienna

OTHER